Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN102115476A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102115476A details a novel room-temperature synthesis for 2-(4-substituted phenyl)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine, offering a streamlined route for kinase inhibitor intermediates with simplified purification.